Patents by Inventor Haijia CHEN

Haijia CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220287952
    Abstract: Disclosed are a method for preparing exosomes from bovine placenta, lyophilized powder of the exosomes, as well as a composition containing exosomes from animal placenta and a preparation method and use thereof in anti-wrinkle on skin.
    Type: Application
    Filed: March 15, 2022
    Publication date: September 15, 2022
    Applicants: GUANGZHOU SALIAI BIOLOGICAL GENETIC ENGINEERING CO., LTD., GUANGZHOU SALIAI STEM CELL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Haijia CHEN, Jiaohua JIANG, Xuejia LI, Jiwang XU, Keliang PANG, Donghuang CHEN, Aimei ZHOU, Li TAO, Zihao CUI, Baoyao LI, Xinming YAN
  • Publication number: 20220251512
    Abstract: The present invention provides a serum-free polypeptide composition for promoting proliferation of mesenchymal stem cells. The composition mainly comprises: 10-100 ?g/L of tripeptide-1; 1-20 ?g/L of tripeptide-2, 1-20 ?g/L of hexapeptide-9, 1-20 ?g/L of palmitoyl hexapeptide-12; and 10-100 ?g/L of a laminin-derived peptide. The serum-free polypeptide composition provided in the present disclosure has clear chemical components without animal origins or serum, can achieve rapid proliferation of the mesenchymal stem cells, and maintains the biological characteristics and immunophenotypic stability of the mesenchymal stem cells while solving the problem of the insufficient quantity of cells.
    Type: Application
    Filed: December 25, 2019
    Publication date: August 11, 2022
    Applicant: GUANGZHOU SALIAI STEM CELL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Haijia CHEN, Xiaohu GE, Xiaoyan WANG, Kangyi QI, Jiaohua JIANG
  • Publication number: 20200288700
    Abstract: The present invention relates to the field of stem cell technology, and in particular to a stem cell preparation and its application in the preparation of drugs for the treatment of osteoarthritis (OA). The composition provided by the invention can significantly improve the activity of umbilical cord mesenchymal stem cells under cryopreservation conditions, and the stem cell preparation prepared therefrom has a good effect on repairing cartilage injury caused by OA, thereby playing a role in the treatment of OA.
    Type: Application
    Filed: November 25, 2019
    Publication date: September 17, 2020
    Applicant: GUANGZHOU SALIAI STEM CELL SCIENCE AND TECHNOLOGY CO., LTD
    Inventors: Haijia CHEN, Xiaohu GE, Xiaoyan WANG, Xuejia LI, Yanyan MA